Optimal therapy for pelvic recurrence after radical hysterectomy for early-stage cervical cancer

Mark E. Potter, Ronald D. Alvarez, Frank L. Gay, Hugh M. Shingleton, Seng Jaw Soong, Kenneth D Hatch

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

Forty-eight patients with pelvic recurrence after radical hysterectomy were evaluated. The influence of location of pelvic recurrence (sidewall versus central), histological grade, histological type, and interval from hysterectomy to recurrence had no influence upon curability by radiotherapy. Ten of twenty-eight patients treated by primary radiation therapy for recurrent disease remain without evidence of disease a minimum of 12 months post-therapy, with a projected 5-year disease-free survival in excess of 30%. No patient treated with adjuvant radiation after initial surgery was rendered disease free by subsequent treatment with radiotherapy. Eleven patients were explored for exenterative surgery. Three of six in whom exenteration was technically feasible remain alive without evidence of disease. None of 15 patients treated with chemotherapy remain free of disease. Radiation therapy remains the treatment of choice in post-radical hysterectomy recurrences confined to the pelvis. As exenterative therapy will result in the cure of a small number of patients with disease confined to the pelvis, exenteration should be considered in patients treated previously by radiotherapy. If these efforts fail, chemotherapy is unlikely to result in cure.

Original languageEnglish (US)
Pages (from-to)74-77
Number of pages4
JournalGynecologic Oncology
Volume37
Issue number1
DOIs
StatePublished - 1990
Externally publishedYes

Fingerprint

Hysterectomy
Uterine Cervical Neoplasms
Recurrence
Radiotherapy
Pelvis
Therapeutics
Drug Therapy
Disease-Free Survival
Radiation

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Oncology

Cite this

Optimal therapy for pelvic recurrence after radical hysterectomy for early-stage cervical cancer. / Potter, Mark E.; Alvarez, Ronald D.; Gay, Frank L.; Shingleton, Hugh M.; Soong, Seng Jaw; Hatch, Kenneth D.

In: Gynecologic Oncology, Vol. 37, No. 1, 1990, p. 74-77.

Research output: Contribution to journalArticle

Potter, Mark E. ; Alvarez, Ronald D. ; Gay, Frank L. ; Shingleton, Hugh M. ; Soong, Seng Jaw ; Hatch, Kenneth D. / Optimal therapy for pelvic recurrence after radical hysterectomy for early-stage cervical cancer. In: Gynecologic Oncology. 1990 ; Vol. 37, No. 1. pp. 74-77.
@article{e0a7c222ff934915a021beef75487413,
title = "Optimal therapy for pelvic recurrence after radical hysterectomy for early-stage cervical cancer",
abstract = "Forty-eight patients with pelvic recurrence after radical hysterectomy were evaluated. The influence of location of pelvic recurrence (sidewall versus central), histological grade, histological type, and interval from hysterectomy to recurrence had no influence upon curability by radiotherapy. Ten of twenty-eight patients treated by primary radiation therapy for recurrent disease remain without evidence of disease a minimum of 12 months post-therapy, with a projected 5-year disease-free survival in excess of 30{\%}. No patient treated with adjuvant radiation after initial surgery was rendered disease free by subsequent treatment with radiotherapy. Eleven patients were explored for exenterative surgery. Three of six in whom exenteration was technically feasible remain alive without evidence of disease. None of 15 patients treated with chemotherapy remain free of disease. Radiation therapy remains the treatment of choice in post-radical hysterectomy recurrences confined to the pelvis. As exenterative therapy will result in the cure of a small number of patients with disease confined to the pelvis, exenteration should be considered in patients treated previously by radiotherapy. If these efforts fail, chemotherapy is unlikely to result in cure.",
author = "Potter, {Mark E.} and Alvarez, {Ronald D.} and Gay, {Frank L.} and Shingleton, {Hugh M.} and Soong, {Seng Jaw} and Hatch, {Kenneth D}",
year = "1990",
doi = "10.1016/0090-8258(90)90311-8",
language = "English (US)",
volume = "37",
pages = "74--77",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Optimal therapy for pelvic recurrence after radical hysterectomy for early-stage cervical cancer

AU - Potter, Mark E.

AU - Alvarez, Ronald D.

AU - Gay, Frank L.

AU - Shingleton, Hugh M.

AU - Soong, Seng Jaw

AU - Hatch, Kenneth D

PY - 1990

Y1 - 1990

N2 - Forty-eight patients with pelvic recurrence after radical hysterectomy were evaluated. The influence of location of pelvic recurrence (sidewall versus central), histological grade, histological type, and interval from hysterectomy to recurrence had no influence upon curability by radiotherapy. Ten of twenty-eight patients treated by primary radiation therapy for recurrent disease remain without evidence of disease a minimum of 12 months post-therapy, with a projected 5-year disease-free survival in excess of 30%. No patient treated with adjuvant radiation after initial surgery was rendered disease free by subsequent treatment with radiotherapy. Eleven patients were explored for exenterative surgery. Three of six in whom exenteration was technically feasible remain alive without evidence of disease. None of 15 patients treated with chemotherapy remain free of disease. Radiation therapy remains the treatment of choice in post-radical hysterectomy recurrences confined to the pelvis. As exenterative therapy will result in the cure of a small number of patients with disease confined to the pelvis, exenteration should be considered in patients treated previously by radiotherapy. If these efforts fail, chemotherapy is unlikely to result in cure.

AB - Forty-eight patients with pelvic recurrence after radical hysterectomy were evaluated. The influence of location of pelvic recurrence (sidewall versus central), histological grade, histological type, and interval from hysterectomy to recurrence had no influence upon curability by radiotherapy. Ten of twenty-eight patients treated by primary radiation therapy for recurrent disease remain without evidence of disease a minimum of 12 months post-therapy, with a projected 5-year disease-free survival in excess of 30%. No patient treated with adjuvant radiation after initial surgery was rendered disease free by subsequent treatment with radiotherapy. Eleven patients were explored for exenterative surgery. Three of six in whom exenteration was technically feasible remain alive without evidence of disease. None of 15 patients treated with chemotherapy remain free of disease. Radiation therapy remains the treatment of choice in post-radical hysterectomy recurrences confined to the pelvis. As exenterative therapy will result in the cure of a small number of patients with disease confined to the pelvis, exenteration should be considered in patients treated previously by radiotherapy. If these efforts fail, chemotherapy is unlikely to result in cure.

UR - http://www.scopus.com/inward/record.url?scp=0025231973&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025231973&partnerID=8YFLogxK

U2 - 10.1016/0090-8258(90)90311-8

DO - 10.1016/0090-8258(90)90311-8

M3 - Article

C2 - 2323616

AN - SCOPUS:0025231973

VL - 37

SP - 74

EP - 77

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 1

ER -